![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Drug Research
Sanofi and Regeneron Announce First  Approval of KevzaraTM for the Treatment of Moderately
Sanofi and Regeneron Pharmaceuticals, Inc announced that Health Canada approved KevzaraTM (sarilumab), an interleukin-6 (IL-6) receptor antibody. For the treatment of...
Press Releases
MDCPartners launches new ta-Scan software that ‘will revolutionize’ the way pharmaceutical companies plan for the future
MDCPartners  launches ta-Scan 5, an update of its global web-based platform that analyses clinical trial data. The new platform is set to revolutionize the...
Drug Research
Novo Nordisk enters collaboration with University of Oxford on type 2 diabetes and invests GBP 115m in new research centre
University of Oxford and Novo Nordisk announced a landmark research collaboration focused on type 2 diabetes. The partnership will enable scientists from Novo Nordisk...
Clinical Trials
Astellas and Ironwood Report Positive Top-Line Results from Phase III Linaclotide Trial
 Astellas Pharma Inc and Ironwood Pharmaceuticals Inc announced top-line results indicating that the Phase III clinical trial of linaclotide conducted in Japan in adults...
Industry Reports
Mallinckrodt Completes Sale Of Its Nuclear Imaging Business To IBA Molecular For Approximately $690 Million
Mallinckrodt plc , a leading specialty pharmaceutical company, announced today that it has closed the sale of its global Nuclear Imaging business to IBA...
Press Releases
Cyprotex, an Evotec Company, Expands into New UK Facility at Alderley Park
Evotec AG announced that Cyprotex, a company wholly owned by Evotec AG, has completed the relocation of its UK operations from Macclesfield to Alderley...
News
Clinerion Introduces New Services for Market Access
Clinerion announces new services for market access which give pharmaceutical companies insight into patient populations based on its health data analytics tools. ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read